Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts

Dathan M. Byonanebye, Mark N. Polizzotto, Fernando Maltêz, Andri Rauch, Katharina Grabmeier‐Pfistershammer, Ferdinand Wit, Stéphane De Wit, Antonella Castagna, Antonella d’Arminio Monforte, Cristina Mussini, Jan‐Christian Wasmuth, Éric Fontas, Irène A. Abela, Mario Sarcletti, Loveleen Bansi‐Matharu, Nadine Jaschinski, Lars Peters, Sean R Hosein, Vani Vannappagari, Cal Cohen, Emiliano Bissio, Amanda Mocroft, Matthew Law, Lene Ryom, Kathy Petoumenos